Substituted C -imidazo[1,2-a]pyridin-3-yl-methylamines

Details Substituted C -imidazo[1,2-a]pyridin-3-yl-methylamines Substituted C -imidazo[1,2-a]pyridin-3-yl-methylamines

2008-03-11

2008-03-11

Seaman, Margaret D. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S121000

Reexamination Certificate

active

07342025

ABSTRACT:
Substituted C-imidazo [1,2-a]pyridine-3-yl methylamines and physiologically acceptable salts thereof, a method for the production thereof, pharmaceutical compositions containing these compounds, and pharmaceutical uses thereof, e.g., as NO synthase inhibitors.

REFERENCES:
patent: 2002/0042420 (2002-04-01), Briem et al.
patent: 2005/0239823 (2005-10-01), Oberboersch et al.
patent: 197 34 184 (1999-02-01), None
patent: 1 536 351 (1968-07-01), None
patent: WO 96/34866 (1996-11-01), None
patent: WO 01/27109 (2001-04-01), None
patent: WO 02/14313 (2002-02-01), None
patent: WO 02/066477 (2002-08-01), None
patent: WO 02/066478 (2002-08-01), None
CASREACT 65:3958, abstract only of Almirante et al,. bollettino Chimico Farmaceutico, 1966, vol. 105, pp. 32-44.
Freshney, Culture of animal cells, a manual of basic technique, 1983, pp. 1-6.□□.
Dermer et al, Bio/Technology, vol. 12, pp. 320, 1994.
International Search Report dated Feb. 10, 2004 (Two (2) pages).
German Search Report dated Jun. 3, 2003 with English translation of relevant portion (Eight (8) pages).
Kamisnki, et al., “Antiulcer Agents. 2. Gastric Antisecretory, Cytoprotective, and Metabolic Properties of Substituted Imidazo[1,2-a]pyridines and Analogues”,J. Med. Chem, vol. 30, 1987, pp. 2031-2046.
Almirante, et al., “Syntheses and Reactions of Imidazoles”,Bollettino Chimico Farmaceutico, vol. 105, No. 1, 1966.
L. H. Lassen, et al., “Nitric oxide synthase inhibition in migraine” The Lancet, vol. 349, Feb. 8, 1997, pp. 401-402.
Lars Lykke Thomsen, et al., “Nitric Oxide Theory of Migraine” Clinical Neuroscience, vol. 5, 1998, pp. 28-33.
P. E. Chabrier, et al., “Nitric oxide synthases: targets for therapeutic strategies in neurological diseases” CMLS, Cell. Mol. Life Science, vol. 55, 1999, pp. 1029-1035.
I. C. Green, et al., “Nitric oxide: from basic research to clinical applications” DDT, vol. 4, No. 2, Feb. 1999, pp. 47-49.
Adrian J. Hobbs, et al., “Inhibition of Nitric Oxide Synthase as a Potential Therapeutic Target” Annu. Rev. Pharmacol. Toxicol, vol. 39, 1999, pp. 191-220.
Houben-Weyl, “1.4.3.5 Addition of Enamines to Iminium Ions”, vol. E 21, pp. 1925-1929.
Merla et al., “Efficient Synthesis of γ-Oxo- and γ -Hydroxy-α-amino Acids”,Synthesis, Nov. 1998, pp. 1609-1614.
Ferid Murad, “Discovery of Some of the Biological Effects of Nitric Oxide and Its Role in Cell Signaling (Nobel Lecture)” Angew. Chem. Int. Ed., vol. 38, 1999, pp. 1857-1868.
Louis J. Ignarro, “Stickstoffmonoxid: ein einzigartiges endogenes Signalmolekuel in der Gefaessbiologie (Nobel-Vortrag)” Angew. Chem. vol. 111, 1999, pp. 2002-2013.

Affiliated with

Also associated with

Rating

Substituted C -imidazo[1,2-a]pyridin-3-yl-methylamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted C -imidazo[1,2-a]pyridin-3-yl-methylamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted C -imidazo[1,2-a]pyridin-3-yl-methylamines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2789790